+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hyperlipidemia Drug"

From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
From
Hyperlipidemia: Competitive Landscape - Product Thumbnail Image

Hyperlipidemia: Competitive Landscape

  • Report
  • January 2025
  • 99 Pages
  • Global
From
Hyperlipidemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hyperlipidemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 1040 Pages
  • Global
From
Hyperlipidemia Market Report 2025 - Product Thumbnail Image

Hyperlipidemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Lipid Regulators Global Market Report 2024 - Product Thumbnail Image

Lipid Regulators Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
From
Hypolipidemics Global Market Report 2024 - Product Thumbnail Image

Hypolipidemics Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Hyperlipidemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hyperlipidemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Antihyperlipidemic Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Antihyperlipidemic Drugs Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Cardiovascular Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cardiovascular Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cardiovascular Therapeutics Market 2024-2028 - Product Thumbnail Image

Cardiovascular Therapeutics Market 2024-2028

  • Report
  • March 2024
  • 183 Pages
  • Global
From
From
From
From
US Hyperlipidemia Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Hyperlipidemia Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Loading Indicator

The Hyperlipidemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of high levels of lipids in the blood. Hyperlipidemia is a condition that can lead to an increased risk of heart disease, stroke, and other cardiovascular diseases. Common treatments for hyperlipidemia include statins, fibrates, and cholesterol absorption inhibitors. Statins are the most commonly prescribed drugs for hyperlipidemia, as they are effective in reducing cholesterol levels. Fibrates are used to reduce triglyceride levels, while cholesterol absorption inhibitors reduce the absorption of cholesterol from the diet. Some companies in the Hyperlipidemia Drug market include Pfizer, Merck, AstraZeneca, Sanofi, and Bristol-Myers Squibb. Show Less Read more